Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccines

被引:16
作者
Ferrier-Rembert, Audrey
Drillien, Robert
Tournier, Jean-Nicolas
Garin, Daniel
Crance, Jean-Marc
机构
[1] Ctr Rech Serv Sante Armees, Unite Virol, F-38702 Grenoble, France
[2] CNRS, UMR7104, INSERM, IGBMC,U596, F-67404 Illkirch Graffenstaden, France
[3] Univ Strasbourg, F-67000 Strasbourg, France
关键词
mouse model; smallpox vaccine; cowpox virus;
D O I
10.1016/j.vaccine.2007.04.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The intranasal infection of mice with cowpox virus (CPXV) has been evaluated as a model for smallpox infection in man. Administration of a lethal dose of CPXV allowed time for development of T-cell responses but antibodies could not be detected before death occurred. In contrast, infection with a sublethal dose was associated with an early T-cell response followed by neutralising antibodies which correlated with virus clearance. Comparison of two first generation smallpox vaccines revealed no significant differences in terms of immunogenicity, protection and post-challenge virus clearance. These studies show that the CPXV/mouse model is valuable for the initial assessment of smallpox vaccines. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4809 / 4817
页数:9
相关论文
共 27 条
[1]   The Soviet Union's anti-agricultural biological weapons [J].
Alibek, K .
FOOD AND AGRICULTURAL SECURITY: GUARDING AGAINST NATURAL THREATS AND TERRORIST ATTACKS AFFECTING HEALTH, NATIONAL FOOD SUPPLIES, AND AGRICULTURAL ECONOMICS, 1999, 894 :18-19
[2]  
BIODEFENSEHENDE.DA, 1999, JAMA-J AM MED ASSOC, V281, P2127
[3]   Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge [J].
Bray, M ;
Martinez, M ;
Smee, DF ;
Kefauver, D ;
Thompson, E ;
Huggins, JW .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :10-19
[4]   Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir [J].
Bray, M ;
Martinez, M ;
Kefauver, D ;
West, M ;
Roy, C .
ANTIVIRAL RESEARCH, 2002, 54 (03) :129-142
[5]   Bioterrorism - Smallpox vaccinations: How much protection remains? [J].
Cohen, J .
SCIENCE, 2001, 294 (5544) :985-985
[6]  
Kohn William G, 2003, MMWR Recomm Rep, V52, P1
[7]   The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection [J].
Coulibaly, S ;
Brühl, P ;
Mayrhofer, J ;
Schmid, K ;
Gerencer, M ;
Falkner, FG .
VIROLOGY, 2005, 341 (01) :91-101
[8]   Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus [J].
Edghill-Smith, Y ;
Golding, H ;
Manischewitz, J ;
King, LR ;
Scott, D ;
Bray, M ;
Nalca, A ;
Hooper, JW ;
Whitehouse, CA ;
Schmitz, JE ;
Reimann, KA ;
Franchini, G .
NATURE MEDICINE, 2005, 11 (07) :740-747
[9]  
*EMEA, 2002, NOT GUID DEV VACC BA
[10]   Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus [J].
Fang, M ;
Sigal, LJ .
JOURNAL OF IMMUNOLOGY, 2005, 175 (10) :6829-6836